| AGIOAGIOS PHARMACEUTICALS, INC. | 5,916,000 | $200.1M |
| CYTKCYTOKINETICS INC | 2,664,538 | $175.6M |
| PTCTPTC THERAPEUTICS, INC. | 2,464,449 | $167.9M |
| TVTXTravere Therapeutics, Inc. | 4,897,417 | $145.5M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 264,583 | $138.5M |
| IMVTImmunovant, Inc. | 5,464,916 | $135.7M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 1,895,347 | $98.0M |
| NBIXNEUROCRINE BIOSCIENCES INC | 724,000 | $95.4M |
| INCYIncyte Corp. | 656,817 | $61.8M |
| DYNDyne Therapeutics, Inc. | 3,175,110 | $57.6M |
| IRWDIRONWOOD PHARMACEUTICALS INC | 15,028,000 | $52.7M |
| HRMYHarmony Biosciences Holdings, Inc. | 1,624,000 | $45.5M |
| NKTRNEKTAR THERAPEUTICS | 578,000 | $41.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 148,000 | $40.0M |
| IMCRImmunocore Holdings plc | 1,188,000 | $35.8M |
| RIGLRIGEL PHARMACEUTICALS INC | 1,280,000 | $34.6M |
| IRONDisc Medicine, Inc. | 536,000 | $34.3M |
| MLYSMineralys Therapeutics, Inc. | 1,176,000 | $31.9M |
| OFIXOrthofix Medical Inc. Common Stock (DE) | 2,700,000 | $31.0M |
| KURAKura Oncology, Inc. | 3,736,000 | $30.4M |
| AVNSAvanos Medical Inc. | 2,000,000 | $28.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 36,126 | $27.9M |
| KALVKalVista Pharmaceuticals, Inc. | 1,236,000 | $24.9M |
| VSTMVerastem, Inc. | 4,592,000 | $24.3M |
| GRFSGrifols S.A. | 2,988,000 | $24.0M |
| SLDBSolid Biosciences Inc. | 3,200,000 | $23.0M |
| AUTLAutolus Therapeutics plc | 15,800,000 | $21.8M |
| ARVNARVINAS, INC. | 1,978,000 | $21.0M |
| ANROAlto Neuroscience, Inc. | 912,000 | $20.5M |
| FDMT4D Molecular Therapeutics, Inc. | 2,000,000 | $18.6M |
| MGNXMACROGENICS INC | 6,012,000 | $17.4M |
| SRRKScholar Rock Holding Corp | 336,959 | $16.6M |
| BCYCBICYCLE THERAPEUTICS PLC | 3,398,000 | $15.8M |
| SNYSanofi | 300,000 | $14.5M |
| VYGRVoyager Therapeutics, Inc. | 3,500,000 | $13.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 236,000 | $13.0M |
| BMYBRISTOL MYERS SQUIBB CO | 205,024 | $12.4M |
| VERAVera Therapeutics, Inc. | 298,164 | $12.0M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 1,328,000 | $11.9M |
| XERSXeris Biopharma Holdings, Inc. | 1,909,838 | $11.1M |
| ESPREsperion Therapeutics, Inc. | 3,930,125 | $10.8M |
| IQVIQVIA Holdings Inc. | 60,884 | $10.4M |
| SGMOSANGAMO THERAPEUTICS, INC | 40,400,067 | $10.0M |
| NPCENeuropace Inc. | 692,000 | $9.1M |
| ZURAZura Bio Ltd | 1,507,000 | $9.0M |
| TMCITreace Medical Concepts Inc. | 6,364,000 | $8.5M |
| GEHCGE HealthCare Technologies Inc. | 118,289 | $8.4M |
| NUVBNuvation Bio Inc. | 1,736,000 | $7.4M |
| KYMRKymera Therapeutics, Inc. | 83,876 | $7.0M |
| ICLRICON plc | 60,268 | $6.7M |
| DVADaVita Inc. | 42,978 | $6.6M |
| SYRESpyre Therapeutics, Inc. | 120,931 | $6.1M |
| EOLSEvolus, Inc. | 1,396,000 | $5.7M |
| CTORCITIUS ONCOLOGY, INC. | 9,188,855 | $5.7M |
| LCTXLineage Cell Therapeutics, Inc. | 3,182,799 | $5.0M |
| ESLAEstrella Immunopharma Inc. | 4,099,000 | $4.3M |
| NTLAIntellia Therapeutics, Inc. | 336,000 | $4.3M |
| PRTAPROTHENA CORP PUBLIC LTD CO | 439,411 | $4.3M |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | 364,000 | $3.4M |
| VRCAVerrica Pharmaceuticals Inc. | 518,181 | $2.7M |
| KYNBKYNTRA BIO INC. | 400,000 | $2.7M |
| BTAIBioXcel Therapeutics, Inc. | 1,910,076 | $2.6M |
| NTRPNeurotrope, Inc. | 675,117 | $2.2M |
| SCLXSCILEX HOLDING CO | 297,706 | $2.0M |
| VVOSVivos Therapeutics Inc. | 1,115,859 | $1.3M |
| IMNNImunon, Inc. | 348,330 | $1.0M |
| OTLKOutlook Therapeutics, Inc. | 4,168,000 | $858K |
| ICCMIceCure Medical Ltd. | 2,712,000 | $816K |
| INBSIntelligent Bio Solutions Inc. | 130,000 | $435K |
| RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. | 592,079 | $432K |
| REVBREVELATION BIOSCIENCES, INC. | 323,241 | $388K |
| GOVXGeoVax Labs, Inc. | 269,253 | $372K |
| MMSIMerit Medical Systems Inc. | 4,448 | $307K |
| QGENQIAGEN N.V. | 6,792 | $272K |
| CLDICalidi Biotherapeutics Inc. | 879,000 | $210K |
| AKTXAkari Therapeutics Plc | 38,922 | $200K |
| VRAXVirax Biolabs Group Ltd | 878,803 | $193K |
| PDSBPDS Biotechnology Corp | 173,605 | $105K |
| CLGNCollPlant Biotechnologies Ltd | 64,000 | $34K |